Jasper Therapeutics (JSPR) Interest & Investment Income (2022 - 2025)
Jasper Therapeutics' Interest & Investment Income was $338,000 in Q4 2025, down 64.0% from $938,000 a year earlier and down 1.2% from the prior quarter.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Interest & Investment Income (2022 - 2025) Analysis & Trends
For FY2025, Interest & Investment Income at Jasper Therapeutics came in at $1.74 million, down 65.6% from FY2024.
- Interest & Investment Income shows a three-year compound annual growth rate of 35.4% (FY2022 to FY2025).
- In earlier years, Interest & Investment Income was $5.06 million in FY2024 (-2.7%), $5.2 million in FY2023 (+641.7%) and $701,000 in FY2022.
- The Q4 2025 figure marks the lowest quarterly Interest & Investment Income since Q3 2022.
- Compared with a year earlier, Interest & Investment Income has declined for six straight quarters, with an average decline of 33.6% over the last eight quarters.
- The best year-over-year quarter for Interest & Investment Income over five years was Q3 2023 (growth of 453.3%); the worst was Q3 2025 (a decline of 73.4%).
- Per Business Quant data, JSPR's Interest & Investment Income in the three quarters before Q4 2025 was $342,000 (Q3 2025), $437,000 (Q2 2025) and $624,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | - |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | - |
| 10 | Jasper Therapeutics | 14.32 Mn | -112.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 338,000.00 |
| Sep 30, 2025 | 342,000.00 |
| Jun 30, 2025 | 437,000.00 |
| Mar 31, 2025 | 624,000.00 |
| Dec 31, 2024 | 938,000.00 |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 348,000.00 |
| Sep 30, 2022 | 259,000.00 |
| Jun 30, 2022 | 92,000.00 |
| Mar 31, 2022 | 2,000.00 |
API Access
Jasper Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=JSPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "JSPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=JSPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();